Zobrazeno 1 - 10
of 21 505 676
pro vyhledávání: '"E A"'
Autor:
Colin C. Everett, Sarah T. Brown, Joanna L. Dennett, Howard Collier, Claire L. Davies, Frances Game, E Andrea Nelson
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background Participant non-response is a source of bias in all research, especially in randomised controlled trials. Participants followed up remotely can have high non-response rates. Four such trials have been conducted of a cover letter w
Externí odkaz:
https://doaj.org/article/00a93ae3dfe6412aa6dd22a96ffd7b1b
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-3 (2024)
Externí odkaz:
https://doaj.org/article/c8bc690aea524f6ca2228ff5667c17df
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 18, Iss 08, Pp 01-05 (2024)
Paraquat, a brown, viscous liquid herbicide known as “N, N’-dimethyl-4,4’-bipyridinium dichloride,” rapidly deactivates upon contact with soil, making it an efficient herbicide with minimal chronic toxicity. However, the prognosis is poor for
Externí odkaz:
https://doaj.org/article/7b6c98c346bd4ed5bedd16f5a7ca2377
Autor:
M Guftar Shaikh, Timothy G Barrett, Nicola Bridges, Robin Chung, Evelien F Gevers, Anthony P Goldstone, Anthony Holland, Shankar Kanumakala, Ruth Krone, Andreas Kyriakou, E Anne Livesey, Angela K Lucas-Herald, Christina Meade, Susan Passmore, Edna Roche, Chris Smith, Sarita Soni
Publikováno v:
Endocrine Connections, Vol 13, Iss 8, Pp 1-30 (2024)
Prader–Willi syndrome (PWS) is a rare orphan disease and complex genetic neurodevelopmental disorder, with a birth incidence of approximately 1 in 10,000–30,000. Management of people with PWS requires a multi-disciplinary approach, ideally throug
Externí odkaz:
https://doaj.org/article/b5e071824fac41ed87e7162b92387652
Autor:
MA Melo, AB Alves-Silva, NP Fonseca, I Weinhuser, ABR Bellomi, FAB Perez, LL Figueiredo-Pontes, JA Machado-Neto, L Quek, P Chatzikyriakou, GA Huls, E Ammatuna, JJ Schuringa, DA Pereira-Martins, F Traina
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S473-S474 (2024)
O inibidor de JAK1/2 aprovado pela FDA, Ruxolitinibe (Ruxo), é utilizado para tratar pacientes com neoplasias mieloproliferativas (NMP), oferecendo boa tolerabilidade e redução dos sintomas constitucionais. No entanto, o efeito do Ruxo na erradica
Externí odkaz:
https://doaj.org/article/cc2fa786788e4fbdb019ff4c2c34e930
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S1176-S1177 (2024)
Introdução: As transfusões sanguíneas são essenciais para o tratamento de condições como perda de sangue, anemias graves e situações críticas. Apesar de sua importância, essas transfusões podem causar reações adversas, variando de leves
Externí odkaz:
https://doaj.org/article/89c94cf17dcd4a6e87dfb5b3619f8850
Autor:
C Pérez-Ingidua, AB Rivas-Paterna, C González-Perrino, E Aleo-Luján, A Ascaso-del-Rio, L Laredo-Velasco, A Portolés-Pérez, E Vargas-Castrillón
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Paediatric patients are especially prone to experiencing adverse drug reactions (ADRs), and the surgical environment gathers many conditions for such reactions to occur. Additionally, little information exists in the literature on
Externí odkaz:
https://doaj.org/article/bb3b6c086acc40258ae2b77b99167854
Autor:
E A. Zhirkova, T. G. Spiridonova, A. V. Sachkov, A. O. Medvedev, E. I. Eliseenkova, I. G. Borisov, M. L. Rogal, S. S. Petrikov
Publikováno v:
Трансплантология (Москва), Vol 16, Iss 1, Pp 64-73 (2024)
Introduction. While developing the algorithms for diagnosis and treatment of patients with thermal injury, an injury outcome prediction index with the best predictive properties should be used.Aim. To compare the predictive properties of the Revised
Externí odkaz:
https://doaj.org/article/332d23bd797a42dbab24375226f8993a
Autor:
David Gómez-Ulloa, M Chris Runken, Wilton I Rodriguez, Basilio Hernández, Montserrat Chivite, E Anne Davis, Paul Nisbet
Publikováno v:
Drugs in Context, Vol 13, Pp 1-14 (2024)
Background: As research continues towards improved treatments for Alzheimer disease (AD), there is growing interest in the views and needs from patients and caregivers on AD treatments. Methods: In this study, we surveyed patients with AD and care
Externí odkaz:
https://doaj.org/article/91a14970666d447788df1b8aa4e14223
Publikováno v:
Armaghane Danesh Bimonthly Journal, Vol 29, Iss 2, Pp 172-184 (2024)
Background & aim: Cyclophosphamide (CP) is an immunosuppressive medication which is primarily used to manage and treatt of neoplasms, including breast cancer, lymphoma and Leukemia. CP as well possesses many side effects, including hepatotoxicity whi
Externí odkaz:
https://doaj.org/article/8612bac4369545f6af86a0f7b88037bc